Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments

被引:5
作者
Bakre, Shivani [1 ]
Chang, Hsien-Yen [2 ]
Doshi, Jalpa A. [3 ,4 ]
Goedel, William C. [5 ]
Saberi, Parya [6 ]
Chan, Philip A. [7 ]
Nunn, Amy [7 ]
Dean, Lorraine T. [1 ,2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA USA
[5] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] Brown Univ, Dept Med, Providence, RI USA
基金
美国国家卫生研究院;
关键词
PREEXPOSURE PROPHYLAXIS; PATIENT ADHERENCE; PROVIDERS;
D O I
10.1001/jamainternmed.2024.3998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Clinicians are a key component of preexposure prophylaxis (PrEP) care. Yet, no prior studies have quantitatively investigated how PrEP adherence differs by clinician specialty. Objective To understand the association between prescribing clinician specialty and patients not picking up (reversal/abandonment) their initial PrEP prescription. Design, Setting, and Participants This cross-sectional study of patients who were 18 years or older used pharmacy claims data from 2015 to 2019 on new insurer-approved PrEP prescriptions that were matched with clinician data from the US National Plan and Provider Enumeration System. Data were analyzed from January to May 2022. Main Outcomes and Measures Clinician specialties included primary care practitioners (PCPs), infectious disease (ID), or other specialties. Reversal was defined as a patient not picking up their insurer-approved initial PrEP prescription. Abandonment was defined as a patient who reversed and still did not pick their prescription within 365 days. Results Of the 37 003 patients, 4439 (12%) were female and 32 564 (88%) were male, and 77% were aged 25 to 54 years. A total of 24 604 (67%) received prescriptions from PCPs, 3571 (10%) from ID specialists, and 8828 (24%) from other specialty clinicians. The prevalence of reversals for patients of PCPs, ID specialists, and other specialty clinicians was 18%, 18%, and 25%, respectively, and for abandonments was 12%, 12%, and 20%, respectively. After adjusting for confounding, logistic regression models showed that, compared with patients who were prescribed PrEP by a PCP, patients prescribed PrEP by ID specialists had 10% lower odds of reversals (odds ratio [OR], 0.90; 95% CI, 0.81-0.99) and 12% lower odds of abandonment (OR, 0.88; 95% CI, 0.78-0.98), while patients prescribed by other clinicians had 33% higher odds of reversals (OR, 1.33; 95% CI, 1.25-1.41) and 54% higher odds of abandonment (OR, 1.54; 95% CI, 1.44-1.65). Conclusion The results of this cross-sectional study suggest that PCPs do most of the new PrEP prescribing and are a critical entry point for patients. PrEP adherence differs by clinician specialties, likely due to the populations served by them. Future studies to test interventions that provide adherence support and education are needed.
引用
收藏
页码:1204 / 1211
页数:8
相关论文
共 50 条
  • [31] Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study
    Ojeda, Victoria D.
    Amico, K. Rivet
    Hughes, James P.
    Wilson, Ethan
    Li, Maoji
    Holtz, Timothy H.
    Chitwarakorn, Anupong
    Grant, Robert M.
    Dye, Bonnie J.
    Bekker, Linda-Gail
    Mannheimer, Sharon
    Marzinke, Mark
    Hendrix, Craig W.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (01) : 34 - 40
  • [32] Decision conflict and the decision support needs of HIV PrEP-eligible Black patients in Toronto regarding the adoption of PrEP for HIV prevention
    Ajiboye, Wale
    Nelson, LaRon
    Odhiambo, Apondi
    Yusuf, Abban
    Djiadeu, Pascal
    Turner, De Anne
    Abubakari, M'Rabiu
    Pedersen, Cheryl
    Brown, Rebecca
    Ni, Zhao
    Guillaume, Genevieve
    Lofters, Aisha
    Williams, Geoffrey
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2022, 21
  • [33] HIV protection with PrEP - implications for controlling other STIs
    Krakower, Douglas S.
    Mayer, Kenneth H.
    NATURE REVIEWS UROLOGY, 2016, 13 (02) : 72 - 73
  • [34] Person-centered HIV PrEP for cisgender women
    Shahmanesh, Maryam
    Chimbindi, Natsayi
    Cowan, Frances M.
    NATURE MEDICINE, 2023, 29 (11) : 2957 - 2957
  • [35] Minority adolescents’ HIV PrEP awareness and preferences in Alabama
    Henna Budhwani
    Ibrahim Yigit
    Hoa L. Nguyen
    Josh Bruce
    C. Lily Bond
    Andrea Johnson
    BMC Research Notes, 18 (1)
  • [36] Amplifying the Population Health Benefits of PrEP for HIV Prevention
    Baeten, Jared M.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (10) : 1509 - 1511
  • [37] PrEP Works and Is a Valuable Addition to the HIV Prevention Toolkit
    Treston, Carole
    Farley, Jason
    Harris, Orlando
    Hoyt, Mary Jo
    Kwong, Jeffrey
    Van Nuys, Jonathan
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2015, 26 (03): : 224 - 226
  • [38] Summary of German-Austrian HIV PrEP guideline
    Spinner, C. D.
    Lang, G. F.
    Boesecke, C.
    Jessen, H.
    Schewe, K.
    Stellbrink, Hans-Juergen
    Esser, Stefan
    Haberl, Annette
    Jessen, Heiko
    Roemer, Katja
    Plettenberg, Andreas
    Rockstroh, Juergen
    Scholten, Stefan
    Spinner, Christoph D.
    Weber, Christoph
    Streeck, Hendrik
    Lang, Gerold Felician
    Haas, Bernhard
    Schewe, Knud
    Lehmann, Clara
    de Leuw, Philipp
    Brockmeyer, Norbert
    Potthoff, Anja
    Schmiedel, Stefan
    Kaiser, Rolf
    Marcus, Ulrich
    Schafberger, Armin
    Schwarze, Siegfried
    Feustel, Nicholas
    Langanke, Harriet
    Claass, Johanna
    HIV MEDICINE, 2019, 20 (06) : 368 - 376
  • [39] PrEP Stigma, HIV Stigma, and Intention to Use PrEP Among Women in New York City and Philadelphia
    Chittamuru, Deepti
    Frye, Victoria
    Koblin, Beryl A.
    Brawner, Bridgette
    Hong-Van Tieu
    Davis, Annet
    Teitelman, Anne
    STIGMA AND HEALTH, 2020, 5 (02) : 240 - 246
  • [40] Returning home sampling kits for STI and HIV testing in people using a digital health HIV-PrEP pathway (PrEP-EmERGE)
    Russell, Annie
    Tasker, Sarah
    Nichols, Kayleigh
    Tweed, Marc
    Darking, Mary
    Whetham, Jennifer
    Richardson, Daniel
    SEXUALLY TRANSMITTED INFECTIONS, 2023, 99 (04) : 289 - 290